| The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups C Curtis, SP Shah, SF Chin, G Turashvili, OM Rueda, MJ Dunning, ... Nature 486 (7403), 346-352, 2012 | 6388 | 2012 |
| Analysis of circulating tumor DNA to monitor metastatic breast cancer SJ Dawson, DWY Tsui, M Murtaza, H Biggs, OM Rueda, SF Chin, ... New England Journal of Medicine 368 (13), 1199-1209, 2013 | 2607 | 2013 |
| The clonal and mutational evolution spectrum of primary triple-negative breast cancers SP Shah, A Roth, R Goya, A Oloumi, G Ha, Y Zhao, G Turashvili, J Ding, ... Nature 486 (7403), 395-399, 2012 | 2359 | 2012 |
| Differential oestrogen receptor binding is associated with clinical outcome in breast cancer CS Ross-Innes, R Stark, AE Teschendorff, KA Holmes, HR Ali, ... Nature 481 (7381), 389-393, 2012 | 2177 | 2012 |
| Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 2009* | 2020 |
| Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA M Murtaza, SJ Dawson, DWY Tsui, D Gale, T Forshew, AM Piskorz, ... Nature 497 (7447), 108-112, 2013 | 1973 | 2013 |
| The landscape of cancer genes and mutational processes in breast cancer PJ Stephens, PS Tarpey, H Davies, P Van Loo, C Greenman, DC Wedge, ... Nature 486 (7403), 400-404, 2012 | 1970 | 2012 |
| The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes B Pereira, SF Chin, OM Rueda, HKM Vollan, E Provenzano, HA Bardwell, ... Nature communications 7 (1), 1-16, 2016 | 1727 | 2016 |
| MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype C Blenkiron, LD Goldstein, NP Thorne, I Spiteri, SF Chin, MJ Dunning, ... Genome biology 8, 1-16, 2007 | 1240 | 2007 |
| A reference map of the human binary protein interactome K Luck, DK Kim, L Lambourne, K Spirohn, BE Begg, W Bian, R Brignall, ... Nature 580 (7803), 402-408, 2020 | 1098 | 2020 |
| Mutations truncating the EP300 acetylase in human cancers SA Gayther, SJ Batley, L Linger, A Bannister, K Thorpe, SF Chin, Y Daigo, ... Nature genetics 24 (3), 300-303, 2000 | 767 | 2000 |
| EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer L Hughes-Davies, D Huntsman, M Ruas, F Fuks, J Bye, SF Chin, J Milner, ... Cell 115 (5), 523-535, 2003 | 546 | 2003 |
| Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer M Murtaza, SJ Dawson, K Pogrebniak, OM Rueda, E Provenzano, J Grant, ... Nature communications 6 (1), 8760, 2015 | 533 | 2015 |
| The shaping and functional consequences of the microRNA landscape in breast cancer H Dvinge, A Git, S Gräf, M Salmon-Divon, C Curtis, A Sottoriva, Y Zhao, ... Nature 497 (7449), 378-382, 2013 | 488 | 2013 |
| Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profiling Y Yuan, H Failmezger, OM Rueda, HR Ali, S Gräf, SF Chin, RF Schwarz, ... Science translational medicine 4 (157), 157ra143-157ra143, 2012 | 482 | 2012 |
| Promoter of lncRNA gene PVT1 is a tumor-suppressor DNA boundary element SW Cho, J Xu, R Sun, MR Mumbach, AC Carter, YG Chen, KE Yost, J Kim, ... Cell 173 (6), 1398-1412. e22, 2018 | 445 | 2018 |
| Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor H Mohammed, C D’Santos, AA Serandour, HR Ali, GD Brown, A Atkins, ... Cell reports 3 (2), 342-349, 2013 | 422 | 2013 |
| High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer SF Chin, AE Teschendorff, JC Marioni, Y Wang, NL Barbosa-Morais, ... Genome biology 8, 1-17, 2007 | 393 | 2007 |
| Multi-omic machine learning predictor of breast cancer therapy response SJ Sammut, M Crispin-Ortuzar, SF Chin, E Provenzano, HA Bardwell, ... Nature 601 (7894), 623-629, 2022 | 387 | 2022 |
| Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups OM Rueda, SJ Sammut, JA Seoane, SF Chin, JL Caswell-Jin, M Callari, ... Nature 567 (7748), 399-404, 2019 | 351 | 2019 |
